News Astal Laboratories Limited

Stocks

MACINTR

INE307N01014

Pharmaceuticals

Market Closed - Bombay S.E. 06:02:31 2026-10-01 EDT			5-day change	1st Jan Change
69.54 ^INR	-1.93%		-0.66%	-19.93%

08-14	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-30	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

All News

Mentions Relevance

08-14	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-30	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-14	Astal Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
01-14	Astal Laboratories Limited announced that it has received INR 2.768732512 billion in funding from a group of investors	CI
12-29	Astal Laboratories signed letter of intent with Immuna Therapeutics GmbH	RE
11-25	Astal Laboratories Limited Receives REACH Compliance Certificate	CI
11-25	Astal Laboratories Limited Secures Letter of Intent for 60 Tonnes of Piroctone Olamine from Swiss Distributor	CI
11-14	Astal Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-10-10	Astal Laboratories to buy 100% of Sriven Pharmachem	RE
25-10-09	Astal Laboratories Limited agreed to acquire Sriven Pharmachem Pvt Ltd for INR 2.6 billion.	CI
25-08-12	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-05-19	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025	CI
25-05-19	Astal Laboratories Limited Constitutes the Csr Committee of Board, Effective May 19, 2025	CI
25-01-28	Astal Laboratories Limited Approves Change in Corporate Office Address	CI
25-01-27	Astal Laboratories Limited Announces Change in the Address of Keeping & Maintaining Books of Accounts place	CI
24-12-23	Astal Laboratories Limited Announces Change in Registered Office Address	CI
24-12-23	Astal Laboratories Limited Appoints Dr. Julius Paul Reinhard Paschke as Independent Director (Non-Executive)	CI
24-11-26	Astal Laboratories Limited announced that it has received INR 37.2993 million in funding	CI
24-10-15	Astal Laboratories Limited Announces Acquisition of Pharmaceutical Intermediates Manufacturing Plant	CI
24-08-06	Astal Laboratories Limited Approves Appointment of Birendrakumar Sahoo as Non Executive Independent Director	CI
24-07-27	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
24-07-05	Astal Laboratories Limited announced that it expects to receive INR 57.1993 million in funding from Aceso Research Labs LLP and other investors	CI
24-05-25	Astal Laboratories Limited Appoints BIRENDRAKUMAR SAHOO as Additional Non-Executive Independent Director	CI
24-05-24	Astal Laboratories Limited Announces Change in Corporate Office Address	CI
24-05-24	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI